Growing at a compound annual growth rate of 9,6%, the global immuno-oncology market is expected to reach a staggering value of $127B by 2026. What breakthroughs have led to these incredible developments and where are we going?
From a rich history to a growing number of therapies, the immuno-oncology landscape has changed rapidly over the last decade.
More about this report:
In this report, we take a look into its past, discuss present therapeutic approaches, and provide an outlook into its exciting future.
